Bpgbio, Inc.

Bpgbio, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be modeled using bespoke Bayesian AI specifically designed for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease.

Company Details

Employees
78
Founded
-
Address
300 3rd Ave, Waltham,massachusetts 02451,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Waltham, Massachusetts
Looking for a particular Bpgbio, Inc. employee's phone or email?

Bpgbio, Inc. Questions

News

BPGbio Welcomes Back NAi Interrogative Biology® Platform - GlobeNewswire

BPGbio Welcomes Back NAi Interrogative Biology® Platform GlobeNewswire

BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM) - Yahoo Finance

BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM) Yahoo Finance

BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease - The Manila Times

BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease The Manila Times

BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025 - BioSpace

BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025 BioSpace

BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence - GlobeNewswire

BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence GlobeNewswire

BPGbio to Present Novel E2-based Targeted Protein Degradation Program at 5th Annual TPD and Induced Proximity Summit in Europe - Silicon Canals

BPGbio to Present Novel E2-based Targeted Protein Degradation Program at 5th Annual TPD and Induced Proximity Summit in Europe Silicon Canals

BPGbio Recognized as 2024 'BioTech AI Company of the Year' by BioTech Breakthrough Awards - Business Wire

BPGbio Recognized as 2024 'BioTech AI Company of the Year' by BioTech Breakthrough Awards Business Wire

BPGbio Appoints Veteran Clinical and Commercial Leader Dr. Brian Berman as Interim Chief Medical Officer - GlobeNewswire

BPGbio Appoints Veteran Clinical and Commercial Leader Dr. Brian Berman as Interim Chief Medical Officer GlobeNewswire

BPGbio Presents New Research on Tumor Metabolism, Immunotherapy, and Diagnostics at AACR Annual Meeting 2025 - Yahoo Finance

BPGbio Presents New Research on Tumor Metabolism, Immunotherapy, and Diagnostics at AACR Annual Meeting 2025 Yahoo Finance

BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025 - GlobeNewswire

BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025 GlobeNewswire

CORRECTING and REPLACING BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa - Business Wire

CORRECTING and REPLACING BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa Business Wire

BPGbio Appoints John Beeler as SVP of Business Development - citybiz

BPGbio Appoints John Beeler as SVP of Business Development citybiz

BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform - BioSpace

BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform BioSpace

BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board - Business Wire

BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board Business Wire

BPGbio Appoints Kenin Spivak to Board of Directors - citybiz

BPGbio Appoints Kenin Spivak to Board of Directors citybiz

BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025 - GlobeNewswire

BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025 GlobeNewswire

BPGbio Announces Appointments to its Leadership Team to Accelerate Research and Commercialization - Business Wire

BPGbio Announces Appointments to its Leadership Team to Accelerate Research and Commercialization Business Wire

Former CDC Director and Renowned Physician-Scientist Dr. Robert Redfield Joins BPGbio Scientific Advisory Board - Business Wire

Former CDC Director and Renowned Physician-Scientist Dr. Robert Redfield Joins BPGbio Scientific Advisory Board Business Wire

Top Bpgbio, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant